Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.81 |
| ▸ | HPGD | P15428 | 2/20 | 0.81 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.81 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.81 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.81 |
| ▸ | ABAT | P80404 | 1/20 | 0.81 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.81 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.60 |
| ▸ | XDH | P47989 | 1/20 | 0.58 |
| ▸ | MAOB | P27338 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | TYR | P14679 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Vanillin SCHEMBL4411107 | 0.97 | ALDH1A1 (0.76) | ALDH1A1HPGDTDP1TRIM24ALDH5A1 | |
| Vanillin SCHEMBL27673973 | 0.92 | ALDH1A1 (0.89) | ALDH1A1HPGDTDP1TRIM24ALDH5A1 | |
| Vanillin SCHEMBL14975994 | 0.92 | ALDH1A1 (0.68) | ALDH1A1HPGDTDP1TRIM24ALDH5A1 | |
| Vanillin SCHEMBL44060 | 0.90 | ALDH1A1 (0.86) | ALDH1A1HPGDTDP1TRIM24ALDH5A1 | |
| Vanillin SCHEMBL1213 | 0.90 | ALDH1A1 (1.00) | ALDH1A1HPGDTDP1TRIM24ALDH5A1 | |
| Vanillin SCHEMBL29354839 | 0.90 | ALDH1A1 (1.00) | ALDH1A1HPGDTDP1TRIM24ALDH5A1 | |
| Vanillin SCHEMBL720723 | 0.90 | ALDH1A1 (1.00) | ALDH1A1HPGDTDP1TRIM24ALDH5A1 | |
| Ethyl Vanillin SCHEMBL28087054 | 0.89 | ALDH1A1 (0.88) | ALDH1A1HPGDTDP1TRIM24ALDH5A1 | |
| Ethyl Vanillin SCHEMBL13516851 | 0.89 | ALDH1A1 (0.88) | ALDH1A1HPGDTDP1TRIM24ALDH5A1 | |
| Vanillin SCHEMBL8853913 | 0.88 | ALDH1A1 (0.96) | ALDH1A1HPGDTDP1TRIM24ALDH5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12324451-B2 | Production of ethanol-free vanilla extracts | SYMRISE AG (DE) | 2025-06-10 | — | — | US | claimed |
| US-20230263202-A1 | Production of Ethanol-free Vanilla Extracts | SYMRISE AG (DE) | 2023-08-24 | — | — | US | claimed |
| CN-113563166-B | Synthesis method of vanillyl alcohol ether | 珠海市柏瑞医药科技有限公司 | 2023-08-01 | — | — | CN | claimed |
| US-20210022381-A1 | Production of Ethanol-free Vanilla Extracts | SYMRISE AG (DE) | 2021-01-28 | — | — | US | claimed |
| EP-3764813-A1 | PRODUCTION OF ETHANOL-FREE VANILLA EXTRACTS | Symrise AG (DE) | 2021-01-20 | — | — | EP | claimed |
| WO-2019174723-A1 | PRODUCTION OF ETHANOL-FREE VANILLA EXTRACTS | SYMRISE AG (DE) | 2019-09-19 | — | — | WO | claimed |
| EP-2861084-A1 | NEUTRALLY BUOYANT INGESTIBLE COMPOSITIONS | Adam, Georgius, Abidal (US) | 2015-04-22 | — | — | EP | claimed |
| WO-2013187897-A1 | NEUTRALLY BUOYANT INGESTIBLE COMPOSITIONS | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2013-12-19 | — | — | WO | claimed |
| US-12324451-B2 | Production of ethanol-free vanilla extracts | SYMRISE AG (DE) | 2025-06-10 | — | — | US | disclosed |
| CN-118420442-B | Method for preparing vanillin by reducing vanillin with silicon powder | 天津市职业大学 | 2024-09-13 | — | — | CN | disclosed |
| CN-118420442-A | Method for preparing vanillin by reducing vanillin with silicon powder | 天津市职业大学 | 2024-08-02 | — | — | CN | disclosed |
| US-20230263202-A1 | Production of Ethanol-free Vanilla Extracts | SYMRISE AG (DE) | 2023-08-24 | — | — | US | disclosed |
| CN-113563166-B | Synthesis method of vanillyl alcohol ether | 珠海市柏瑞医药科技有限公司 | 2023-08-01 | — | — | CN | disclosed |
| US-11672266-B2 | Production of ethanol-free vanilla extracts | SYMRISE AG (DE) | 2023-06-13 | — | — | US | disclosed |
| WO-2008027533-A2 | PERSONAL CARE COMPOSITIONS COMPRISING PEAR SEED EXTRACT | THE PROCTER & GAMBLE COMPANY (US) | 2008-03-06 | — | — | WO | disclosed |
| US-20070196296-A1 | Personal care compositions | PROCTER & GAMBLE COMPANY, THE | 2007-08-23 | — | — | US | disclosed |
| US-20070185038-A1 | Regulation of mammalian keratinous tissue using skin care actives | THE PROCTER & GAMBLE COMPANY | 2007-08-09 | — | — | US | disclosed |
| US-20070183993-A1 | Personal care compositions | PROCTER & GAMBLE COMPANY, THE | 2007-08-09 | — | — | US | disclosed |
| WO-2007041548-A2 | COMPOSITION FOR REGULATION OF MAMMALIAN KERATINOUS TISSUE | THE PROCTER & GAMBLE COMPANY (US) | 2007-04-12 | — | — | WO | disclosed |
| WO-2007001904-A2 | PERSONAL CARE COMPOSITIONS COMPRISING ALPHA-GLUCANS AND/OR BETA-GLUCANS | THE PROCTER & GAMBLE COMPANY (US) | 2007-01-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070196296-A1 | Personal care compositions | CUTA, C5, F7 | ALDH1A1 3550/4885HPGD 1444/4885TDP1 1957/4885 |
| US-20070183993-A1 | Personal care compositions | PPARG, PPARA, PPARD | ALDH1A1 2805/4885HPGD 662/4885TDP1 2918/4885 |
| US-20070185038-A1 | Regulation of mammalian keratinous tissue using skin care actives | CUTA, KDM7A, KDM2A | ALDH1A1 3455/4885HPGD 2220/4885TDP1 812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.